|
| PPD Confirms Takeda Receives FDA Complete Response For Alogliptin |
2 Jul 09, 04:48 |
|
| PPD, Inc. today announced that Takeda Pharmaceutical Company Limited issued a news release reporting that Takeda Global Research & Development Center, Inc., its wholly-owned U.S. subsidiary, has received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for alogliptin. |
| more |
|
